Literature DB >> 16043894

Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.

Kiyoshi Yamada1, Ingo Brink, Emmanuel Bissé, Thomas Epting, Rupert Engelhardt.   

Abstract

Using human (SK-MEL 23, SK-MEL 24 and G361) and murine (B16) melanoma cell lines, the coregulatory potential of the uptake of the positron emission tomography (PET) tracer, [Fluorine-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) has been investigated in relationship to tumor characteristics. Comparative studies among the four melanoma cell lines demonstrated that the lowest FDG uptake in SK-MEL 24 corresponded strongly to the data for DT (population doubling time) and MTT (tetrazolium salt) cell viability as well as hexokinase (HK) activity, but was not related to the glucose transporter 1 (GLUT 1) expression level. Furthermore, the FDG uptake in each melanoma cell line measured by cell cycle kinetics was significantly positively correlated to both the proliferation index (PI=S/G2M phase fractions) and the cell viability, though with one exception relating to the PI of the lowest FDG uptake cell line, SK-MEL 24. No positive correlation was found between the expression of GLUT 1 and FDG uptake in any individual cell line. However, the HK activities in SK-MEL 23 and 24 showed considerable positive relationships with FDG uptake. Our present study suggests that both the proliferation rate and the cell viability of melanoma cells may be key factors for FDG uptake and that HK activity, rather than GLUT 1 expression, seems to be a major factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043894     DOI: 10.1111/j.1346-8138.2005.tb00903.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  18 in total

1.  False positive 18F-FDG PET/CT due to gynaecomastia.

Authors:  R Ramtahalsing; A I J Arens; R F A Vliegen; G J J Teule; P L A van den Ende; R G H Beets-Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-25       Impact factor: 9.236

2.  [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.

Authors:  Coralie Chaise; Emmanuel Itti; Yolande Petegnief; Evelyne Wirquin; Christiane Copie-Bergman; Jean-Pierre Farcet; Marie-Hélène Delfau-Larue; Michel Meignan; Jean-Noël Talbot; Valérie Molinier-Frenkel
Journal:  Cancer Immunol Immunother       Date:  2006-12-14       Impact factor: 6.968

3.  Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines.

Authors:  Eleonore Fröhlich; Inge Fink; Richard Wahl
Journal:  Invest New Drugs       Date:  2008-09-20       Impact factor: 3.850

4.  BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume.

Authors:  Nicholas Theodosakis; Matthew A Held; Alexander Marzuka-Alcala; Katrina M Meeth; Goran Micevic; Georgina V Long; Richard A Scolyer; David F Stern; Marcus W Bosenberg
Journal:  Mol Cancer Ther       Date:  2015-05-06       Impact factor: 6.261

5.  Lactic Acid Accumulation in the Tumor Microenvironment Suppresses 18F-FDG Uptake.

Authors:  Silvan Türkcan; Louise Kiru; Dominik J Naczynski; Laura S Sasportas; Guillem Pratx
Journal:  Cancer Res       Date:  2018-12-03       Impact factor: 12.701

6.  p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis.

Authors:  Nicholas Theodosakis; Goran Micevic; Casey G Langdon; Alessandra Ventura; Robert Means; David F Stern; Marcus W Bosenberg
Journal:  J Invest Dermatol       Date:  2017-06-07       Impact factor: 8.551

7.  A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features.

Authors:  Maria Lucia Calcagni; Maria Vittoria Mattoli; Maria Antonietta Blasi; Gianluigi Petrone; Maria Grazia Sammarco; Luca Indovina; Antonino Mulè; Vittoria Rufini; Alessandro Giordano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-04       Impact factor: 9.236

8.  Heterogeneity in intratumor correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in canine sinonasal tumors.

Authors:  Tyler J Bradshaw; Stephen R Bowen; Ngoneh Jallow; Lisa J Forrest; Robert Jeraj
Journal:  J Nucl Med       Date:  2013-09-16       Impact factor: 10.057

9.  Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancer.

Authors:  Nicholas Theodosakis; Casey G Langdon; Goran Micevic; Irina Krykbaeva; Robert E Means; David F Stern; Marcus W Bosenberg
Journal:  Pigment Cell Melanoma Res       Date:  2018-10-22       Impact factor: 4.693

10.  The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.

Authors:  A Slominski; T-K Kim; A A Brożyna; Z Janjetovic; D L P Brooks; L P Schwab; C Skobowiat; W Jóźwicki; T N Seagroves
Journal:  Arch Biochem Biophys       Date:  2014-07-02       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.